Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
M Megna, C Patruno, MR Bongiorno… - Journal of …, 2022 - Taylor & Francis
… psoriasis that are known to increase the risk of reactivation of TBC infection. In our study, there
were no cases of active TBC or TBC reactivation among 59 psoriasis patients … %) patients …
were no cases of active TBC or TBC reactivation among 59 psoriasis patients … %) patients …
Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
… patients undergoing IT in which no viral reactivation was observed. Only one case of HCV
reactivation during treatment with ustekinumab for psoriasis is reported in the literature [25]. …
reactivation during treatment with ustekinumab for psoriasis is reported in the literature [25]. …
Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: a retrospective cohort study and systematic review of the literature
… Because these agents lack direct hepatic or renal toxicity, 3 … ) reactivation following
TNF-α–inhibitor use in patients with … the safety of all biologics in psoriasis patients exposed to HBV …
TNF-α–inhibitor use in patients with … the safety of all biologics in psoriasis patients exposed to HBV …
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
HY Chiu, YM Chiu, NFC Liao, CC Chi, TF Tsai… - Journal of the American …, 2021 - Elsevier
… the context of psoriasis. 10, 11, 12, 13, 14 However, studies on predictors for HBVr and HCVr
in patients with psoriasis treated with biologics in a real-world setting are lacking. Moreover…
in patients with psoriasis treated with biologics in a real-world setting are lacking. Moreover…
[HTML][HTML] Risk of reactivation of latent tuberculosis in psoriasis patients on biologic therapies: a retrospective cohort from a tertiary care centre in northern Italy
L Mastorino, P Dapavo, M Trunfio… - Acta dermato …, 2022 - ncbi.nlm.nih.gov
… , further complicate the risk assessment of TB reactivation in psoriatic patients treated with
biologics (9). The percentage of psoriatic patients with LTBI in Europe is approximately 20%, …
biologics (9). The percentage of psoriatic patients with LTBI in Europe is approximately 20%, …
Risk of tuberculosis reactivation during interleukin‐17 inhibitor therapy for psoriasis: a systematic review
E Fowler, RI Ghamrawi, N Ghiam… - Journal of the …, 2020 - Wiley Online Library
… TB reactivation. Although not included in our systematic review, we found no case reports
of TB reactivation in patients treated with IL-17 inhibitors. A limitation of our study is a lack of …
of TB reactivation in patients treated with IL-17 inhibitors. A limitation of our study is a lack of …
[HTML][HTML] Risk of reactivation of hepatitis B virus infection in psoriasis patients treated with biologics: a retrospective analysis of 20 cases from the BIOBADADERM …
J Sanz-Bueno, F Vanaclocha, I García-Doval… - Actas Dermo …, 2015 - Elsevier
… has been reported in patients with diseases other than psoriasis treated with … reactivation
in patients with a past history of HBV infection who were receiving biologic therapy for psoriasis…
in patients with a past history of HBV infection who were receiving biologic therapy for psoriasis…
Risk of hepatitis B reactivation in patients with psoriasis on ustekinumab
SW Ting, YC Chen, YH Huang - Clinical Drug Investigation, 2018 - Springer
… of hepatitis B virus (HBV) reactivation among psoriasis patients with varying HBV status who
… the lack of any breach of patient privacy. Adult patients with moderate-to-severe psoriasis …
… the lack of any breach of patient privacy. Adult patients with moderate-to-severe psoriasis …
Risk for hepatitis b virus reactivation in patients with psoriasis treated with biological agents: A systematic review and meta-analysis
X Wang, M Zhang, Y Chen, Y Liu, Y Yu, X Huang… - Dermatology and …, 2022 - Springer
… patients with psoriasis are at high risk of virus reactivation when … HBV reactivation and serious
complications in HBsAg-positive … The lack of antiviral treatment in these individuals would …
complications in HBsAg-positive … The lack of antiviral treatment in these individuals would …
Relapse, rebound, and psoriasis adverse events: an advisory group report
W Carey, S Glazer, AB Gottlieb, M Lebwohl… - Journal of the American …, 2006 - Elsevier
… of psoriasis, including T-cell activation, T-cell trafficking from the circulation into the skin, and
T-cell reactivation … be selected for patients who discontinued efalizumab because of lack of …
T-cell reactivation … be selected for patients who discontinued efalizumab because of lack of …
相关搜索
- patients with psoriasis systematic review
- patients with psoriasis biologic therapies
- patients with psoriasis concurrent hepatitis
- patients with psoriasis real world setting
- patients with psoriasis tuberculosis reactivation
- patients with psoriasis hepatitis b reactivation
- patients with psoriasis effectiveness of ustekinumab
- patients with psoriasis efalizumab therapy
- patients with psoriasis predictors of hepatitis
- patients with psoriasis virus reactivation
- patients with psoriasis cohort study
- patients with psoriasis retrospective study
- patients with psoriasis meta analysis
- patients with psoriasis safety profile
- patients with psoriasis risk for hepatitis
- tuberculosis in patients lack of reactivation